The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences
Drugs & drug processes
Tick (check) box to add article to PDF "basket"
An EU- and industry-funded project has developed a mobile app enabling patients and healthcare professionals to more easily report suspected adverse drug reactions. It has also analysed social media to assess drug safety. Both initiatives have shown potential for strengthening the monitoring of medicines.
Published: 18 June 2018
Pre-eclampsia is a potentially life-threatening condition that can develop in pregnant women. A number of factors are known to increase the risk, but the actual causes of this hypertensive disorder remain unclear. Researchers in Kazakhstan were involved in an EU-funded project that discovered an exciting lead: the babys genes also appear to play a role.
Published: 11 June 2018
An EU- and industry-funded project has identified potential biomarkers that could indicate how likely a drug is to cause cancer at an earlier stage of testing than is currently possible, which could save drug companies time and money - and lead to safer drugs reaching patients faster.
Published: 8 June 2018
An international group of EU-funded researchers has investigated the safety and efficacy of using the drug deferiprone to treat children with the blood disorder beta-thalassaemia major. The news is good.
Published: 1 June 2018
EU-funded researchers have shown how nanoparticles can deliver drugs directly to the site of an infection. This preclinical research promises more effective treatments and the prospect of bypassing the threat of antimicrobial resistance.
Published: 29 May 2018
Hundreds of millions of people each year are infected with Plasmodium vivax, the most widespread form of malaria worldwide. An EU-funded project is tackling the mosquito-borne parasite, leading cutting-edge research efforts to accelerate the development of effective vaccines.
Published: 25 April 2018
EU-funded researchers are using the latest vaccine technologies and antigen discovery tools to develop a multi-stage, multi-antigen vaccine against Plasmodium falciparum, the parasite responsible for the deadliest form of malaria.
Published: 25 April 2018
A potential drawback of clinical trials of new drugs is that they do not always reflect how well these will work in the 'real world'. EU and industry-funded research brought together key stakeholders to help add more such evidence into the design of trials, increasing confidence in new medicines and helping to get them to patients more quickly.
Published: 28 February 2018
An EU-and industry-funded project has created an integrated platform which is providing an innovative range of free services, expertise and a huge collection of compounds for researchers who are developing new drugs to treat all types of human diseases.
Published: 26 February 2018
Using innovative nanotechnologies, an EU-funded project is developing more efficient and sustainable vaccine manufacturing processes. The cost of vaccines puts a brake on wider immunisation, so these new processes will find broad application - especially in developing economies.
Published: 19 February 2018